Azide-alkyne cycloaddition en route to 1H-1,2,3-triazole-tethered 7-chloroquinoline-isatin chimeras: synthesis and antimalarial evaluation.

[1]  Vipan Kumar,et al.  Azide-alkyne cycloaddition en route towards 1H-1,2,3-triazole-tethered β-lactam-ferrocene and β-lactam-ferrocenylchalcone conjugates: synthesis and in vitro anti-tubercular evaluation. , 2013, Dalton transactions.

[2]  Vipan Kumar,et al.  Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation. , 2012, European journal of medicinal chemistry.

[3]  Vipan Kumar,et al.  Azide-alkyne cycloaddition en route to novel 1H-1,2,3-triazole tethered isatin conjugates with in vitro cytotoxic evaluation. , 2012, European journal of medicinal chemistry.

[4]  Vipan Kumar,et al.  Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy. , 2012, Bioorganic & medicinal chemistry.

[5]  Vipan Kumar,et al.  Synthesis and in vitro anti-tubercular evaluation of 1,2,3-triazole tethered β-lactam-ferrocene and β-lactam-ferrocenylchalcone chimeric scaffolds. , 2012, Dalton transactions.

[6]  Vipan Kumar,et al.  Antiplasmodial and cytotoxicity evaluation of 3-functionalized 2-azetidinone derivatives. , 2011, Bioorganic & medicinal chemistry letters.

[7]  Maria M. M. Santos,et al.  Design, synthesis and evaluation of 3-methylene-substituted indolinones as antimalarials. , 2011, European journal of medicinal chemistry.

[8]  A. Gómez-Barrio,et al.  Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation. , 2009, European journal of medicinal chemistry.

[9]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[10]  D. Skropeta,et al.  Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008. , 2009, Anti-cancer agents in medicinal chemistry.

[11]  Vipan Kumar,et al.  Synthetic medicinal chemistry of selected antimalarial natural products. , 2009, Bioorganic & medicinal chemistry.

[12]  C. Kaiser,et al.  Synthesis and in vitro antitubercular activity of a series of quinoline derivatives. , 2009, Bioorganic & medicinal chemistry.

[13]  B. Meunier,et al.  Hybrid molecules with a dual mode of action: dream or reality? , 2008, Accounts of chemical research.

[14]  A. Bell,et al.  A novel artemisinin-quinine hybrid with potent antimalarial activity. , 2007, Bioorganic & medicinal chemistry letters.

[15]  P. Yogeeswari,et al.  Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs. , 2005, European journal of medicinal chemistry.

[16]  P. Yogeeswari,et al.  Synthesis and evaluation of anti-HIV activity of isatin β-thiosemicarbazone derivatives , 2005 .

[17]  Kelly Chibale,et al.  Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives. , 2005, Bioorganic & medicinal chemistry.

[18]  M. Pirrung,et al.  Combinatorial optimization of isatin-beta-thiosemicarbazones as anti-poxvirus agents. , 2005, Journal of medicinal chemistry.

[19]  S. Pandeya,et al.  Biological activities of isatin and its derivatives. , 2005, Acta pharmaceutica.

[20]  H. Kolb,et al.  The growing impact of click chemistry on drug discovery. , 2003, Drug discovery today.

[21]  Jochen Wiesner,et al.  New antimalarial drugs. , 2003, Angewandte Chemie.

[22]  P. Yogeeswari,et al.  Towards the design and development of agents with broad spectrum chemotherapeutic properties for the effective treatment of HIV / AIDS. , 2003, Current medicinal chemistry.

[23]  K. Chibale,et al.  Synthesis and antiplasmodial activity in vitro of new ferrocene–chloroquine analogues , 2003 .

[24]  S. Katiyar,et al.  Perspective in antimalarial chemotherapy. , 2003, Current medicinal chemistry.

[25]  J. Gallo,et al.  Pharmacodynamic-Mediated Effects of the Angiogenesis Inhibitor SU5416 on the Tumor Disposition of Temozolomide in Subcutaneous and Intracerebral Glioma Xenograft Models , 2003, Journal of Pharmacology and Experimental Therapeutics.

[26]  P. Roepe,et al.  Chloroquine resistance in the malarial parasite, Plasmodium falciparum , 2002, Medicinal research reviews.

[27]  T. Egan.  Structure-function relationships in chloroquine and related 4-aminoquinoline antimalarials. , 2001, Mini reviews in medicinal chemistry.

[28]  P. Rosenthal,et al.  Comparison of Efficacies of Cysteine Protease Inhibitors against Five Strains of Plasmodium falciparum , 2001, Antimicrobial Agents and Chemotherapy.

[29]  H. Ginsburg,et al.  Heme Degradation in the Presence of Glutathione , 1995, The Journal of Biological Chemistry.

[30]  D. L. Klayman,et al.  Qinghaosu (artemisinin): an antimalarial drug from China , 1985 .

[31]  Vipan Kumar,et al.  1,2,3-Triazole tethered β-lactam-chalcone bifunctional hybrids: synthesis and anticancer evaluation. , 2012, European journal of medicinal chemistry.

[32]  V. Rosário,et al.  Mechanisms of Drug Resistance in Malaria: Current and New Challenges , 2006 .

[33]  S. Katiyar,et al.  Current trends in antimalarial chemotherapy , 2003 .

[34]  J. Jensen.  In vitro culture of Plasmodium parasites. , 2002, Methods in molecular medicine.